Ignite Creation Date:
2024-05-06 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03589222
Status:
UNKNOWN
Last Update Posted:
2021-02-04
First Post:
2018-06-12
Brief Title:
SELIBORDARA Selinexor Bortezomib and Daratumumab in Multiple Myeloma
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-12
First Submit QC Date:
July 4 2018
Study First Post Date:
2018-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-03
Last Update Post Date:
2021-02-04
Last Update Post Date Type:
ACTUAL